24 May 2013
Keywords: fda, approves, pfizer, maraviroc, world, drug, giant
Article | 13 August 2007
World drug giant Pfizer's CCR5 antagonist maraviroc has been approved as a treatment for patients infected with CCR5-tropic HIV-1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 August 2007
© 2013 thepharmaletter.com